⚠ STRICT REGULATORY DIRECTIVE: INDUSTRIAL R&D SUPPLY ONLY
This technical dossier is engineered exclusively for biochemical procurement directors, pharmacologists, and clinical formulation scientists. We operate strictly as a primary B2B manufacturer of Active Pharmaceutical Ingredients (APIs) and research peptides. The Melanotan II (MT-2) material discussed herein is designed solely for in-vitro laboratory research, pre-clinical melanogenesis studies, and commercial-scale biochemical manufacturing. We categorically refuse to supply finished retail products for direct human consumption.
API Procurement & Quality Control
The Melanotan II Sourcing Crisis: Why Cyclic Peptide Purity Dictates R&D Success (CAS 121062-08-6)
In the highly specialized field of dermatological research and MC1R agonism, relying on grey-market "research chemicals" is a critical vulnerability. This whitepaper exposes the biochemical challenges of synthesizing cyclic heptapeptides and explains why transitioning to a cGMP-verified Melanotan II API manufacturer is the only way to secure reproducible clinical baselines.
The global demand for Melanotan II (MT-2) in photoprotection and melanogenesis research has surged. As a highly potent, non-selective agonist of the melanocortin receptors (particularly MC1R, MC3R, and MC4R), it exhibits a robust ability to induce eumelanin production independent of damaging ultraviolet (UV) exposure. However, the commercial supply chain is plagued by severe quality discrepancies. When R&D labs procure bulk Melanotan II from unverified chemical brokers, they frequently encounter high levels of synthetic impurities, drastically skewing receptor binding kinetics and ruining months of costly in-vitro assays.
The Biochemical Barrier: Why is True Melanotan II So Difficult to Synthesize?
Structurally, Melanotan II is a lactam-bridged, cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Unlike basic linear peptides, synthesizing MT-2 requires the precise formation of an internal lactam bridge between the Aspartic acid (Asp) and Lysine (Lys) side chains.
Substandard manufacturers utilizing outdated Solid-Phase Peptide Synthesis (SPPS) techniques frequently fail to execute this cyclization completely. This results in bulk powders contaminated with "linear MT-2 precursors" or deletion sequences. These structural impurities are molecularly similar to the target peptide but exhibit entirely unpredictable pharmacodynamics, often acting as receptor antagonists rather than agonists. Procuring ultra-pure Melanotan II API ensures the spatial conformation is perfectly locked, guaranteeing accurate, reproducible target receptor engagement.
The Imperative of ≥99.0% HPLC Purity in Formulation
For formulation engineers designing aqueous solutions or advanced liposomal delivery systems, raw material purity dictates the entire stability curve. Trace amounts of trifluoroacetic acid (TFA) residue or unreacted cleavage solvents found in low-grade MT-2 can drastically lower the pH of your formulation, triggering rapid peptide hydrolysis. Our rigorously purified Melanotan II raw material undergoes extensive preparative chromatography, stripping out these hazardous residuals. This guarantees a highly stable, completely transparent dissolution in bacteriostatic water or standard physiological buffers.
Technical Specification Matrix (API Release Standards)
| Product Identity | Melanotan II Acetate (Synthetic Cyclic Heptapeptide) |
|---|
| CAS Registry Number | 121062-08-6 |
|---|
| Molecular Formula / Weight | C50H69N15O9 / 1024.18 g/mol |
|---|
| Chromatographic Purity | HPLC ≥ 99.0% |
|---|
| Identity Verification | Mass Spectrometry (MS) conforming to 1024.18 Da |
|---|
| Physical State & Storage | White lyophilized powder. Store strictly at -20°C. |
|---|
Procurement FAQ: Managing Cold-Chain & Stability
+ How does the API purity affect solubility for R&D formulations?
Achieving ≥99.0% purity eliminates hydrophobic truncated sequences and cross-linked polymers. This guarantees rapid, completely clear dissolution in standard aqueous buffers (such as PBS or bacteriostatic water) without the risk of particulate suspension, precipitation, or micelle formation during your formulation processes.
+ How is the -20°C temperature requirement managed during transoceanic shipping?
To prevent peptide oxidation and hydrolysis during transit, we deploy validated medical-grade cold-chain logistics. The MT-2 lyophilized powder is vacuum-sealed in moisture-barrier aluminum foil pouches, packed into insulated EPS containers with regulated cooling agents (e.g., dry ice), ensuring sub-zero stability from our manufacturing plant to your laboratory doors.
+ Do you supply full COA and MS documentation for QA audits?
Absolutely. Transparency is the core of B2B chemical procurement. Every commercial batch is dispatched with a comprehensive Certificate of Analysis (COA), including raw HPLC chromatograms and Mass Spectrometry (MS) spectra, enabling seamless integration into your facility's internal compliance audits.
Bypass the Broker Network. Source Your Peptide Direct.
Protect your research and formulations from synthetic impurities. Secure a highly stable, scalable supply of ≥99.0% HPLC-verified Melanotan II API directly from the manufacturing source.
Betty | Senior Independent Site Operations
📧 betty@pharma-sunrise.com💬 WhatsApp: +86 18092760627
